enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. 15 Alternatives to Ozempic for Weight Loss - AOL

   www.aol.com/15-alternatives-ozempic-weight-loss...

   Oral weight loss medications like metformin and Topamax. ... As with many drugs on this list, it’s FDA-approved for people who have type 2 diabetes, but it’s often prescribed off-label for ...

3. Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss?

   www.aol.com/diabetes-drugs-really-safe-reliable...

   A one-month supply of brand-name weight loss injections costs around the following, though prices may vary based on your location, your dose, and other factors: Ozempic: $1,029 Wegovy: $1,430

4. Over-the-counter drug - Wikipedia

   en.wikipedia.org/wiki/Over-the-counter_drug

   Some drugs may be legally classified as over-the-counter (i.e. no prescription is required), but may only be dispensed by a pharmacist after an assessment of the patient's needs or the provision of patient education. Regulations detailing the establishments where drugs may be sold, who is authorized to dispense them, and whether a prescription ...

5. Walgreens launches own brand of opioid overdose reversal drug

   www.aol.com/news/walgreens-launches-own-brand...

   Walgreens' spray would be sold at a retail price of $34.99 per pack, with each pack containing two single doses of 4 milligrams each. The OTC version of Emergent BioSolutions' Narcan is sold at ...

6. Canagliflozin - Wikipedia

   en.wikipedia.org/wiki/Canagliflozin

   Canagliflozin is indicated to be used with diet and exercise to lower blood sugar in adults with type 2 diabetes; to reduce the risk of major heart-related events such as heart attack, stroke, or death in people with type 2 diabetes who have known heart disease; and to reduce the risk of end-stage kidney disease, worsening of kidney function, heart-related death, and being hospitalized for ...

7. Alogliptin - Wikipedia

   en.wikipedia.org/wiki/Alogliptin

   Alogliptin, sold under the brand names Nesina and Vipidia, [2] [3] is an oral anti-diabetic drug in the DPP-4 inhibitor (gliptin) class. [4] Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of hypoglycemia, and has relatively modest glucose-lowering activity. [1]

8. Gliclazide - Wikipedia

   en.wikipedia.org/wiki/Gliclazide

   Gliclazide, sold under the brand name Diamicron among others, is a sulfonylurea type of anti-diabetic medication, used to treat type 2 diabetes. [7] It is used when dietary changes, exercise, and weight loss are not enough. [4]

9. Empagliflozin/metformin - Wikipedia

   en.wikipedia.org/wiki/Empagliflozin/metformin

   Empagliflozin/metformin was approved for use in the European Union in May 2015. [6] Empagliflozin/metformin was approved for use in the United States in August 2015. [7] [12] The extended release version was approved for use in the United States in December 2016. [13] [14] Empagliflozin/metformin was approved for use in Australia in May 2020. [2]